---
layout: default
title: Acetaminophen Micronized
parent: 僅模型預測 (L5)
nav_order: 30
evidence_level: L5
indication_count: 0
---

# Acetaminophen Micronized
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Acetaminophen Micronized: Insufficient Data for Repurposing Prediction

---

## One-Sentence Summary

Acetaminophen Micronized is a particle-size-reduced formulation of the well-known analgesic and antipyretic acetaminophen (paracetamol), commonly used for mild-to-moderate pain relief and fever reduction.
The TxGNN model returned **no predicted new indications** for this compound, likely due to the absence of a matched DrugBank ID for the micronized formulation variant.
Without a TxGNN score or supporting evidence, a formal repurposing evaluation cannot proceed at this stage.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Analgesic / Antipyretic (general pharmaceutical knowledge; no TFDA registration data available) |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only — not applicable; no prediction generated) |
| Singapore Market Status | ✗ Not Marketed |
| Number of Registrations | 0 |
| Recommended Decision | **Hold** |

---

## Why is This Prediction Reasonable?

No TxGNN repurposing prediction is available for this entry. The pipeline query log shows that a DrugBank lookup was attempted and returned one result (`result_count: 1`), but no `drugbank_id` was successfully mapped into the candidate record. Without a valid DrugBank identifier, TxGNN cannot traverse the knowledge graph to generate disease associations.

Acetaminophen (INN: paracetamol) is one of the most widely used over-the-counter analgesics globally, with a well-characterised mechanism involving cyclooxygenase inhibition in the central nervous system and modulation of the endocannabinoid system. The "micronized" designation refers to a pharmaceutical particle-size reduction process intended to improve dissolution rate and bioavailability — it is the same active moiety, not a distinct chemical entity.

To unlock TxGNN predictions, the canonical DrugBank entry for acetaminophen (DB00316) should be explicitly linked to this candidate before re-running the prediction pipeline.

---

## Singapore Market Information

This drug is currently **not registered** in Singapore under the Health Sciences Authority (HSA). No license records are available.

---

## Safety Considerations

Please refer to the package insert for safety information. No DDI records, contraindications, or key warnings were retrieved during the current data collection cycle.

> **Note for reviewers:** The TFDA package insert (仿單) was flagged as a blocking data gap (DG001). Until this document is retrieved and parsed, a formal safety profile cannot be constructed.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The absence of TxGNN predictions, a missing DrugBank ID linkage, and zero Singapore regulatory registrations mean there is no actionable repurposing signal to evaluate at this time. The underlying active ingredient (acetaminophen) is well-characterised, but this specific formulation variant has not been processed through the full pipeline.

**To proceed, the following is needed:**

1. **Resolve DrugBank ID mapping** — Explicitly assign DrugBank ID `DB00316` (acetaminophen) to this candidate and re-run the TxGNN prediction pipeline (`scripts/run_kg_prediction.py`)
2. **Retrieve TFDA package insert** — Download and parse the TFDA 仿單 PDF to populate key warnings, contraindications, and MOA fields (Data Gap DG001, severity: Blocking)
3. **Confirm formulation intent** — Clarify whether "micronized" is being evaluated as a standalone entity or as a formulation variant of standard acetaminophen; this determines whether a separate evidence collection run is warranted
4. **Re-run evidence collection** — After DrugBank ID is resolved, re-run ClinicalTrials.gov and PubMed collectors to populate the evidence pack
5. **HSA registration check** — Verify whether any acetaminophen micronized products are under pending HSA registration or are covered under existing acetaminophen monograph approvals in Singapore
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

